Compensatory Smoking With Very Low Nicotine Content Cigarettes: A Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

Compensatory Smoking With Very Low Nicotine Content Cigarettes: A Systematic Review and Meta-Analysis

  • By

  • Rachel L. Denlinger-Apte

  • Ziyu Ji

  • Emily A. Harwood

  • Darcy Lockhart

  • Neal L. Benowitz

  • Dana Mowls Carroll

  • Rachel N. Cassidy

  • Suzanne M. Colby

  • Eric C. Donny

  • Diann E. Gaalema

  • Brandy W. Hardy

  • Dorothy K. Hatsukami

  • Sarah H. Heil

  • Stephen T. Higgins

  • Xianghua Luo

  • F. Joseph McClernon

  • Stacey C. Sigmon

  • Tracy T. Smith

  • Andrew A. Strasser

  • Jennifer W. Tidey

  • David M. Vock

  • Cassidy M. White

  • Jack M. Wolf

  • Joseph S. Koopmeiners

  • July 15, 2026

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Wake Forest University School of Medicine
    Wake Forest University School of Medicine

    Winston-Salem, North Carolina

    Key Differentiators

    • Public Health
    • Tobacco Research

  • #2

    University of Minnesota
    University of Minnesota

    Minneapolis, Minnesota

    Key Differentiators

    • Public Health
    • Tobacco Research

  • #3

    Penn State University College of Medicine
    Penn State University College of Medicine

    Hershey, Pennsylvania

    Key Differentiators

    • Public Health
    • Clinical Trials

Original Source(s)

Compensatory Smoking With Very Low Nicotine Content Cigarettes: A Systematic Review and Meta-Analysis

  • by Rachel L. Denlinger-Apte, Ziyu Ji, Emily A. Harwood, Darcy Lockhart, Neal L. Benowitz, Dana Mowls Carroll, Rachel N. Cassidy, Suzanne M. Colby, Eric C. Donny, Diann E. Gaalema, Brandy W. Hardy, Dorothy K. Hatsukami, Sarah H. Heil, Stephen T. Higgins, Xianghua Luo, F. Joseph McClernon, Stacey C. Sigmon, Tracy T. Smith, Andrew A. Strasser, Jennifer W. Tidey, David M. Vock, Cassidy M. White, Jack M. Wolf, Joseph S. Koopmeiners

  • July 15, 2026

Related Content

Predictive modeling for survival-related outcomes in lung cancer patients with brain metastases: a mini-review

Multimodal machine learning predicts type 2 respiratory failure in COPD exacerbations: a multicenter XGBoost model with clinical nomogram

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report